Biotech
Serán Bioscience
Serán Bioscience raises $200M Venture at $900M valuation
$200M
Total Raised
Venture
Latest Round
2017
Founded
300+
Employees
Bend, OR
1 min read
Quick Facts
Valuation
$900M
Latest Round Size
$200M
Latest Round Date
October 2024
Serán Bioscience: Venture Funding Round
Serán Bioscience has successfully raised $200M in Venture funding, reaching a valuation of $900M.
Company Overview
Provides development and manufacturing services to pharmaceutical and biotech companies
Funding Details
The Venture round was led by Foresite Capital, with participation from OrbiMed.
Company Information
- Headquarters: Bend, OR
- Founded: 2017
- Employees: 300+
- Category: Biotech
Investment
Serán Bioscience plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Venture
- OrbiMed: Verified investor in Venture
Key Investors
Foresite Capital
Lead Investor
Verified investor in Venture
OrbiMed
Investor
Verified investor in Venture
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M